Viewing Study NCT03637868


Ignite Creation Date: 2025-12-24 @ 5:29 PM
Ignite Modification Date: 2026-02-24 @ 12:13 AM
Study NCT ID: NCT03637868
Status: WITHDRAWN
Last Update Posted: 2020-05-06
First Post: 2018-08-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Eribulin in Brain Metastases From HER2-negative Breast Cancer
Sponsor: Institut Paoli-Calmettes
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER2-negative breast cancer View
None brain metastases View